Cervical Cytokine Profile in High-Grade Squamous Intraepithelial Lesions.
Talles Henrique de Araújo Pontes1, Amaxsell Thiago Barros de Souza1, Carolina de O Mendes-Aguiar1,2
1Postgraduate Program in Science Applied to Women's Health, Federal University of Rio Grande Do Norte, Natal, Brazil.
Summary
High-grade squamous intraepithelial lesions (HSIL) show reduced tumor necrosis factor (TNF) and interleukin-2 (IL-2) levels, indicating an immune shift. This suggests potential for new biomarkers and therapies in HPV-related cervical disease.
Area of Science:
- Immunology
- Gynecologic Oncology
- Cellular Biology
Background:
- High-grade squamous intraepithelial lesions (HSIL) are precursors to cervical cancer.
- The local immune environment plays a critical role in HPV-associated cervical disease progression.
- Understanding cytokine profiles in HSIL is crucial for developing targeted interventions.
Purpose of the Study:
- To characterize the cervicovaginal cytokine milieu in women with HSIL compared to healthy controls.
- To investigate the balance of pro-inflammatory and regulatory immune responses in HSIL.
- To identify potential cytokine-based biomarkers for HPV-associated cervical disease.
Main Methods:
- Case-control study involving 84 women (57 HSIL, 27 controls).
- Cervicovaginal lavage fluid analyzed for IL-2, IL-4, IL-6, IL-10, TNF, IFN-γ, and IL-17A using Cytometric Bead Array.
- Calculation of cytokine ratios to assess immune balance; Mann-Whitney test for statistical analysis.
Main Results:
- Women with HSIL had significantly lower concentrations of TNF and IL-2 compared to controls.
- Reduced TNF/IL-10 and TNF/IL-4 ratios in HSIL suggest impaired Th1-mediated immune activation.
- No significant differences in IL-17A levels or IL-17A/IL-6 ratios were observed, indicating Th17 pathways may not be primary drivers.
Conclusions:
- HSIL is characterized by reduced TNF and IL-2 expression, with a suppressed TNF/IL-10 and TNF/IL-4 balance.
- This indicates a shift towards an immunoregulatory profile, independent of Th17 activity.
- The identified cytokine signature offers a framework for developing biomarkers and immunotherapies for HPV-associated cervical disease.

